Keywords: CEl-SCI Corp, Multikine, Advertising, USA, FDA, Head and neck cancer

CEL-SCI gets FDA warning letter about web site statements on Multikine

Article | 22 August 2011

Print This

US drug developer CEL-SCI Corp (NYSE AMEX: CVM) says it received a warning letter received from the Division of Drug ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in